SBH Sciences
Private Company
Funding information not available
Overview
SBH Sciences is a long-established, privately-held biotech services and product company that functions as a specialized CRO and innovation hub. With over 28 years of operation, it has built a reputation for providing cost-effective, high-quality research tools (cytokines, antibodies, enzymes) and development services (bioassays, biomarker analysis) to the global biotech industry. Its unique 'SBH Hub' model combines CRO services, venture building, diagnostics, and incubation to accelerate client programs from discovery to IND, primarily serving startup companies and entrepreneurial scientists.
Technology Platform
Integrated suite for biologics development: proprietary recombinant cytokine/antibody manufacturing, extensive cell-based assay library (~400 cancer cell lines, >360 assays), and GLP-compliant biomarker/bioanalytical testing services.
Opportunities
Risk Factors
Competitive Landscape
SBH competes in the fragmented CRO and life science reagents market. It differentiates through deep specialization in cell-based assays and cytokines, a lean and cost-effective service model attractive to startups, and its unique integrated ecosystem that combines services, venture building, and incubation. Key competitors include large CROs (Charles River, LabCorp), specialty assay providers, and reagent manufacturers like PeproTech and R&D Systems.